Weill Cornell Medicine has been awarded a five-year, $11.6 million grant from the National Institute on Drug Abuse of the National Institutes of Health to study the effects cannabis, including marijuana and compounds derived from it, may have on the brains of those living with HIV.
A new biotech and pharmaceutical management program offered through the Cornell Jeb E. Brooks School of Public Policy will allow students to explore industry trends and cutting edge research with a cohort of peers, executives and renowned faculty from the university.
380 graduates in the Class of 2023 received their degrees from Weill Cornell Medicine during the institution’s annual commencement ceremony at Carnegie Hall on May 18.
Weill Cornell Medicine’s debt-reduction program was created in 2019 to cover tuition, fees, housing and living expenses for students with financial need.
For her work in developing and teaching nutrition and food justice curricula to adolescents in New York City, Hannah Rudt ’23 has won the 2023 National Student Employee of the Year award – the first Cornellian to ever receive this honor.
A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment.
Patients with HIV had similar treatment outcomes to patients without HIV when treated for mpox with an antiviral drug called tecovirimat, according to a new study.
Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell Medicine and NewYork-Presbyterian investigators.
